All posts by: Michael Zand

About Michael Zand

Two CAR-T Cancer Immunotherapy Trials on Clinical Hold After Patient Death – P&T Community

Continue reading

2017-09-05 NEWS

Xconomy

Two CAR-T Cancer Immunotherapy Trials on Clinical Hold After Patient Death
P&T Community
The FDA has placed a clinical hold on two gene-edited allogeneic CAR T-cell (UCART) phase 1 studies being conducted by Cellectis after the report of a patient death. The studies are evaluating UCART123 immunotherapy in patients with acute myeloid …
Patient Death Triggers FDA Hold For Cellectis’s “Off the Shelf” CAR-TXconomy
Here’s​ ​Why Cellectis SA Fell as Much as 31.6% TodayMotley Fool
After Patient Death, FDA Places Clinical Hold on Cellectis CAR-T Candidate UCART123Genetic Engineering & Biotechnology News

all 23 news articles »

Continue reading

2017-09-05 NEWS

Liberty Nation (registration) (blog)

FDA Commissioner Announces Stem Cell Enforcement Shift, Plans to Develop Comprehensive Regenerative Medicine …
The National Law Review
In a major public move that has been long-awaited by proponents of evidence-based stem cell science, FDA Commissioner Scott Gottlieb issued a lengthy statement on August 28, 2017 “on the FDA’s new policy steps and enforcement efforts to ensure proper …
FDA Scrutinizing Stem Cell ClinicsFinancial Advisor Magazine (registration)
Stem cell: Obama revives volatile debateIndependent Online
FDA crackdown on unproven stem cell therapiesBioNews
Liberty Nation (registration) (blog) –Guardian Liberty Voice –Medgadget (blog)
all 21 news articles »
Continue reading

2017-09-05 NEWS

Experts Laud FDA’s Stepped-Up Stem Cell Efforts
Bloomberg BNA
The FDA’s new plans to crack down on “unscrupulous” stem cell clinics but also speed up new therapy development is welcome and necessary, experts said. Food and Drug Administration Commissioner Scott Gottlieb announced Aug. 28 his agency will …

Continue reading

2017-09-05 NEWS

Financial Times

Japan’s stemcell race
Financial Times
An audio version of the best of the Financial Times’s Big Reads — in-depth reporting from FT correspondents around the world. Listen to longform stories that explore and explain key themes in world news, science and business. Produced by Anna Dedhar.

Continue reading

2017-09-05 NEWS

Liberty Nation (registration) (blog)

FDA Scrutinizing Stem Cell Clinics
Financial Advisor Magazine (registration)
On Monday, the Food and Drug Administration released a warning letter it sent last week to Florida-based U.S. Stem Cell Inc. for selling unapproved stemcell treatments and injecting them into patients’ spinal cords. And it raided a San Diego-based
Obama to expand stem cells researchIndependent Online
Stem Cell Assay Sales Market 2017 to 2022 Global Research, Analysis and ForecastMedgadget (blog)
Stem Cells and “Mishandling” SmallpoxLiberty Nation (registration) (blog)
Guardian Liberty Voice –Digital Journal –WhaTech
all 18 news articles »
Continue reading

2017-09-05 NEWS

FierceBiotech

Takeda joins CART chasing pack with Noile-Immune alliance
FierceBiotech
The move into CART is a logical one for Takeda, which has already made a foray into cell-based therapies with the formation of its T-CiRA program—based out of its Shonan Research Center in Japan—which is focusing on developing stem cell therapies
Takeda to partner with cancer immunotherapy startupThe Japan Times

all 3 news articles »